Seal Rock Therapeutics

Seal Rock Therapeutics

Biotechnology, 500 Yale Ave N, Seattle, Washington, 98109, United States, 1-10 Employees

sealrocktx.com

  • LinkedIn

phone no Phone Number: 20********

Who is SEAL ROCK THERAPEUTICS

Seal Rock Therapeutics, Inc. is discovering and developing small molecule inhibitors of ASK1 (apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and f...

Read More

map
  • 500 Yale Ave N, Seattle, Washington, 98109, United States Headquarters: 500 Yale Ave N, Seattle, Washington, 98109, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7299

checked-icon Does something look wrong? Fix it. | View contact records from SEAL ROCK THERAPEUTICS

Seal Rock Therapeutics Org Chart and Mapping

Employees

David Brown

Director of Chemistry

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Seal Rock Therapeutics

Answer: Seal Rock Therapeutics's headquarters are located at 500 Yale Ave N, Seattle, Washington, 98109, United States

Answer: Seal Rock Therapeutics's phone number is 20********

Answer: Seal Rock Therapeutics's official website is https://sealrocktx.com

Answer: Seal Rock Therapeutics's revenue is $1 Million to $5 Million

Answer: Seal Rock Therapeutics's SIC: 7299

Answer: Seal Rock Therapeutics has 1-10 employees

Answer: Seal Rock Therapeutics is in Biotechnology

Answer: Seal Rock Therapeutics contact info: Phone number: 20******** Website: https://sealrocktx.com

Answer: Seal Rock Therapeutics, Inc. is discovering and developing small molecule inhibitors of ASK1 (apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological and neurodegenerative indications.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access